Last update 14 Nov 2024

Lorundrostat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Lorundrostat Hydrobromide, MLS-101, MT 4129
Target
Mechanism
ALDOS inhibitors(Cytochrome P450 11B2 inhibitors)
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H34BrN7O2
InChIKeyXQIXTASWTUQJIA-HBUVDCARSA-N
CAS Registry2765632-49-1

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Resistant hypertensionPhase 3
US
22 Nov 2023
Resistant hypertensionPhase 3
AU
22 Nov 2023
Resistant hypertensionPhase 3
BG
22 Nov 2023
Resistant hypertensionPhase 3
CA
22 Nov 2023
Resistant hypertensionPhase 3
FR
22 Nov 2023
Resistant hypertensionPhase 3
DE
22 Nov 2023
Resistant hypertensionPhase 3
IT
22 Nov 2023
Resistant hypertensionPhase 3
NL
22 Nov 2023
Resistant hypertensionPhase 3
PL
22 Nov 2023
Resistant hypertensionPhase 3
PR
22 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
200
Placebo
(Placebo - Part 1)
nmcxqzahjm(guywimqssh) = mdoazytzkx ojuscdewsb (dpdpmyezph, jjknwjebzd - wwmsgalwox)
-
05 Jan 2024
(Lorundrostat 12.5 mg BID - Part 1)
nmcxqzahjm(guywimqssh) = lukuqmwhqz ojuscdewsb (dpdpmyezph, egazgutzpc - ffyvfxgtot)
Phase 2
200
jqgaogyjpa(whmehiobmw) = xvvwkfkfgt fnmofngkms (vnnrzoyasa )
Positive
11 Nov 2023
ocbtzisonq(gftsjmrdti) = ptdimujbeh knzinmfqci (ousgryjyeb )
Phase 2
200
lorundrostat 12.5 mg
qsgoqpvgws(cfbmrqqudm) = ucbpzwmgzq qexmgcmhbb (zbjhuoitvc )
Positive
10 Sep 2023
qsgoqpvgws(cfbmrqqudm) = lksmntynwb qexmgcmhbb (zbjhuoitvc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free